Overview
Location
United States, California, Danville
Employees
1-10
Phone
+1 925-263-9483
Mentions in press and media 6
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Aug 8, 2014 | Pain, pain go away: Scilex Pharmaceuticals snags $5 million for lidocaine patch | The drug, if approved, would compete in a market expected to open up with next year’s patent expiration of Lidoderm, a lidocaine patch developed and marketed by Endo. Endo (NASDAQ: ENDP), based in Dublin, Ireland, has its U.S. headquarters ... |
| Jul 24, 2012 | Chronic pain drug developer for cancer, lower back pain raises $3M | Location: Blue Bell, Pennsylvania Industry: Pharmaceuticals Solution/product: Its lead product is chronic pain treatment LevoCap, a proprietary once-a-day extended release dosage form of the opioid levorphanol. It is being presented as an a... |
| Aug 12, 2011 | Pain management device firm ReGear raises $500K | ReGear is hoping to push the investment up to $750,000, according to a regulatory filing. The company started out in the sports and military markets, having licensed its technology from the U.S. Navy. But for ReGear, the big money lies in t... |
| Pain, pain go away: Scilex Pharmaceuticals snags $5 million for lidocaine patch | Specialty pain meds maker Scilex Pharmaceuticals plans to wrap up clinical trials for its lead product, Ztildo – and has just raised $5 million from private investors to do so, according to regulatory filings. Ztildo is a lidocaine patch de... | |
| Chronic pain drug developer for cancer, lower back pain raises $3M | Company name: Relmada Therapeutics Location: Blue Bell, Pennsylvania Industry: Pharmaceuticals Solution/product: Its lead product is chronic pain treatment LevoCap, a proprietary once-a-day extended release dosage form of the opioid levorph... |